In a proof-of-concept trial, researchers have obtained encouraging results for a medicine to treat premenstrual dysphoric disorder (PMDD)—a mood disorder affecting 3% to 5% of women of childbearing…
Read More
In a proof-of-concept trial, researchers have obtained encouraging results for a medicine to treat premenstrual dysphoric disorder (PMDD)—a mood disorder affecting 3% to 5% of women of childbearing…
Read More